Circulating microRNAs in head and neck cancer: a scoping review of methods

2019 ◽  
Vol 36 (3) ◽  
pp. 291-302 ◽  
Author(s):  
Nuwan Dharmawardana ◽  
Eng Hooi Ooi ◽  
Charmaine Woods ◽  
Damian Hussey
2019 ◽  
Vol 100 (12) ◽  
pp. 2381-2388 ◽  
Author(s):  
Sara C. Parke ◽  
Sonal Oza ◽  
Sam Shahpar ◽  
An Ngo-Huang ◽  
Aliea Herbert ◽  
...  

2021 ◽  
pp. e20200068
Author(s):  
Joni Nedeljak ◽  
Susan Armijo-Olivo ◽  
Ivonne A. Hernandez ◽  
Suresh Nayar ◽  
Margaret L. McNeely

Purpose: Trismus, or restricted mouth opening, is a common side effect of treatment for head and neck cancer. This scoping review examined the characteristics, extent, and nature of existing research on manual therapy and jaw-mobilizing devices to prevent and manage trismus related to head and neck cancer. Method: Six electronic databases were searched using the terms trismus, head and neck cancer, and physical therapy and the associated MeSH terms. The review focused on the factors related to intervention delivery: timing, adherence, completion rates, and adverse events. Results: Nine studies were included. Eight examined the use of a jaw-mobilizing device, and one explored the benefit of remote telephone support. Two studies involved cancer survivors at risk of trismus, five involved survivors with trismus, and two included survivors both with and at risk of trismus. No studies were found examining physiotherapist provision of manual therapy. Within-group comparisons supported the benefit of using a jaw-mobilizing device to manage trismus, whereas significant between-groups differences were found only in non-randomized controlled trials. Survivor symptoms and intervention burden were reported reasons for poor adherence and completion rates. Conclusions: No benefit was found for the use of jaw-mobilizing devices for the prevention of trismus. Given the potential of manual therapy to enhance outcomes, physical therapist–led research is warranted.


2021 ◽  
Author(s):  
Itziar Alonso ◽  
Laura Lopez-Perez ◽  
Juan Carlos Martin Guirado ◽  
Maria Fernanda Cabrera-Umpierrez ◽  
Maria Teresa Arredondo ◽  
...  

2018 ◽  
Vol 41 (17) ◽  
pp. 2093-2107 ◽  
Author(s):  
Ana Maria Rodriguez ◽  
Alyssa Komar ◽  
Jolie Ringash ◽  
Catherine Chan ◽  
Aileen M. Davis ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-12 ◽  
Author(s):  
Shree Ram Lamichhane ◽  
Thanuja Thachil ◽  
Harriet Gee ◽  
Natalie Milic

Background. Circulating microRNAs (miRNAs) are potential molecular biomarkers for cancer detection; however, little is known about their prognostic role in head and neck cancer. This current study is aimed at evaluating the role of novel miRNAs in the survival of head and neck cancer patients. Materials and Methods. We performed a systematic literature search using online databases for articles published between December 2006 and February 2019. A meta-analysis was conducted to assess the correlation between miRNA expressions and overall survival (OS) among the selected head and neck cancer studies. After multilevel screening by reviewers, meta-analysis was performed using hazard ratios (HR) and associated 95% confidence interval (CI) of survival to calculate a pooled effect size. Result. A total of 1577 patients across 13 studies were included in the literature review, with 18 miRNAs upregulated and 4 miRNAs downregulated predicting a poor overall survival. The forest plot generated using cumulated survival data resulted in a pooled HR value of 2.943 (95% CI: 2.394-3.618) indicating a strong association of dysregulated miRNA expression with a poor outcome. Only 2 miRNAs—low levels of miR-9 and high levels of miR-483-5p—were observed in two studies, both showing a significant association with overall cancer survival. Conclusion. To our knowledge, this is the first comprehensive systematic review and meta-analysis that examines the prognostic role of circulating miRNAs from blood in head and neck cancer patients. The combined effect estimates a HR across multiple studies and also supports the previous individual findings that an alteration in miRNA expression is highly associated with poor prognosis. This has the potential to use serum and/or plasma miRNAs as biomarkers and become novel tools for predicting the prognosis of head and neck cancer patients in the near future.


2020 ◽  
Vol 28 (10) ◽  
pp. 4613-4625 ◽  
Author(s):  
Bárbara Ferrão ◽  
Pedro Miguel Neves ◽  
Teresa Santos ◽  
Manuel Luís Capelas ◽  
Antti Mäkitie ◽  
...  

2013 ◽  
Vol 8 (1) ◽  
pp. 296 ◽  
Author(s):  
Isolde Summerer ◽  
Maximilian Niyazi ◽  
Kristian Unger ◽  
Adriana Pitea ◽  
Verena Zangen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document